Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rangering i aksjer #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aksjekurs
$0.617
Sist synkronisert: 2024-10-14
Markedsverdi
$6.13M
Endring (1 dag)
0.49%
Endring (1 år)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Kategori

EPS for Kineta, Inc. (KA)
EPS per March 2025 TTM: $-0.66
Ifølge de siste økonomiske rapportene og aksjekursen til Kineta, Inc. er selskapets nåværende EPS (TTM) $-0.66. Ved slutten av 2023 hadde selskapet en EPS på $-1.28, en nedgang sammenlignet med EPS-en i 2022 som var $-12.80.
EPS-historikk for Kineta, Inc. fra 2015 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -2,724.24%
US
$27.74 -4,303.03%
NL
- -
CH
- -
KR
$13.70 -2,175.77%
BE